Sign In
Buy REGN
$618.95
+16.03 (+2.66%)
At Close: Jun 03, 2026
Trump says US pharma tariffs coming in not-too-distant future
12:26pm, Monday, 14'th Apr 2025
U.S. President Donald Trump said on Monday that he expects to impose tariffs on imported pharmaceuticals in the not-too-distant future.
Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages
10:30am, Friday, 11'th Apr 2025
President Donald Trump's planned tariffs on pharmaceuticals imported into the U.S. could have wide-ranging consequences on the drug supply chain, manufacturers and American patients, some experts told
This Pharma Giant Will Invest $23 Billion in the U.S. It's a Sign Trump's Tariffs Are Working.
08:28am, Friday, 11'th Apr 2025
The Company spend billions to produce 100% of its key medicines for Americans in the U.S.
Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkback
04:45am, Thursday, 10'th Apr 2025
European stocks soared on Thursday after U.S. President Donald Trump's jarring about-turn on most tariffs. Tensions between Washington and Beijing remain high, however, with Trump ratcheting up duties
BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks
06:32pm, Wednesday, 09'th Apr 2025
Evan Seigerman, BMO, joins 'Fast Money' to talk the impact of tariffs on pharma space.
Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out
03:59pm, Wednesday, 09'th Apr 2025
The Trump administration's proposed tariffs on pharmaceuticals have caused significant market turmoil today, with major Pharma stocks plummeting globally. Despite pledges to increase U.S. manufacturin
Explainer: Prescription drugs become a target in Trump's trade war
02:27pm, Wednesday, 09'th Apr 2025
U.S. President Donald Trump late on Tuesday reiterated he would impose tariffs on imports of pharmaceutical products that have long been spared from past trade disputes due to the potential for harm t
Healthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'
01:06pm, Wednesday, 09'th Apr 2025
Trump doubled down on plans to soon impose "major" pharmaceutical tariffs, while early stage startups dominated digital health funding deals in first quarter.
4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street
08:09am, Monday, 07'th Apr 2025
As biotech investors know, companies in the industry can sometimes earn significant returns in relatively short periods, like a year, thanks to excellent clinical or regulatory progress. And based on
Regeneron: Market Overlooks A Resilient Franchise And Robust Free Cash Flow
02:36am, Sunday, 06'th Apr 2025
Regeneron's Eylea franchise remains resilient despite biosimilar competition, with Eylea HD showing strong performance and new innovations like a pre-filled syringe on the horizon. Dupixent continues
3 Growth Stocks That Have Turned $1,000 Into More Than $100,000 in 20 Years
03:23am, Saturday, 05'th Apr 2025
Three stocks which have generated 100-bagger returns for investors over the past 20 years are Booking Holdings (BKNG -3.58%), Apple (AAPL -7.28%), and Regeneron Pharmaceuticals (REGN -6.11%). Here's a
RFK Jr. 'needs a lot of help and expertise' on science, says Regeneron CEO
09:34am, Tuesday, 01'st Apr 2025
Regeneron CEO Leonard Schleifer on Tuesday said that Health and Human Services Secretary Robert F. Kennedy Jr.
Regeneron CEO Leonard Schleifer on tariffs: Let's make sure the Europeans pay their fair share
08:23am, Tuesday, 01'st Apr 2025
Regeneron founder, chair and CEO Leonard Schleifer joins 'Squawk Box' to discuss the impact of President Trump's tariff policies on biotech and pharmaceuticals, his thoughts on HHS Secretary RFK Jr.,
3 Stocks to Watch in the Evolving Cell-Based Ophthalmic Therapy Space
10:10am, Monday, 31'st Mar 2025
ALC, GKOS and REGN are well-positioned to benefit from the evolving space of cell-based ophthalmic therapy.
Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils
